Compare PBT & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBT | VALN |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 874.4M | 855.8M |
| IPO Year | N/A | 2021 |
| Metric | PBT | VALN |
|---|---|---|
| Price | $18.14 | $9.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $15.75 |
| AVG Volume (30 Days) | ★ 67.9K | 13.1K |
| Earning Date | 03-13-2026 | 03-19-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | $17,266,423.00 | ★ $211,089,992.00 |
| Revenue This Year | N/A | $3.64 |
| Revenue Next Year | N/A | $12.23 |
| P/E Ratio | $55.30 | ★ N/A |
| Revenue Growth | N/A | ★ 13.48 |
| 52 Week Low | $8.01 | $5.17 |
| 52 Week High | $20.46 | $12.25 |
| Indicator | PBT | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 44.46 |
| Support Level | $17.64 | $9.20 |
| Resistance Level | $19.18 | $10.09 |
| Average True Range (ATR) | 0.59 | 0.29 |
| MACD | -0.07 | -0.12 |
| Stochastic Oscillator | 27.18 | 13.90 |
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.